Reviewed 8 Oct 2026
Completeness Fair (22%)
As part of ART-Plan. ART-Plan is an AI-based software platform developed by TheraPanacea to support radiotherapy treatment planning workflows. The platform provides authorized users with a set of software modules designed to assist in the preparation, assessment, and management of radiotherapy treatment planning activities using medical imaging data. ART-Plan operates through a user account system that provides access to functions based on predefined user rights and permissions. The system supports both Cloud and On-premise deployments. The software includes tools for image and plan import, organization, analysis, and processing of medical imaging data used during the radiotherapy planning process. Depending on the modules installed and licensed, ART-Plan supports activities such as contouring organs at risk or tumors, automated protocol-based treatment plan generation based on predicted class solution, and adaptive treatment assessment based on AI-generated synthetic-CT. The tasks are automated, can be performed simultaneously on multiple patients, and the results are exported to the Treatment Planning System for further review, editing and approval.
No papers to support — we monitor for new evidence.
Key features
Adaptive Radiotherapy
General Information
Product name
Company
Workflow phase
Modality
Treatment site
Exact structures
Regulatory Information
Pathway:
MDR
Class:
Class IIb
Verified by Health AI Register
Other certifications
Not specified
Evidence & Research
No research papers or evidence on file yet.
The registry monitors publications for new evidence.
Technical Specifications
Prerequisites
Not specified
Defined prerequisite(s)
Not specified
Treatment technique
Not specified
Delivery system
Not specified
Workflow features
Not specified
Patient population age
Not specified
Input
Not specified
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Integration method
Not specified
API documentation availability
Not specified
API documentation, if publicly available
Not specified
TPS compatibility
Not specified
Deployment
Not specified
Trigger for AI functionality
Not specified
Processing time
Not specified
Retraining locally
Not specified
Claims
Not specified
Known limitations
Not specified
Market Presence
On market since
Not specified
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
First published: Jul 6, 2026 | Last updated: Oct 8, 2026